Biopharmaceuticals are complex medicines made from living cells or organisms. They advance more treatment options for patients, some of whom suffer from untreated or undertreated conditions.

Teva is investing in both original biologic medicines and in biosimilars (highly similar versions to specific innovator biologics) to help patients around the world. We are focusing on treatments for the central nervous system, respiratory conditions, and in the field of oncology.

Take a look behind the scenes